CRIS Current Research Information System

FAVONI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.738
NA - Nord America 2.658
EU - Europa 1.423
SA - Sud America 210
AF - Africa 112
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.146
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.614
VN - Vietnam 934
SG - Singapore 744
CN - Cina 482
IT - Italia 285
GB - Regno Unito 268
HK - Hong Kong 239
DE - Germania 211
SE - Svezia 159
BR - Brasile 158
FR - Francia 100
IN - India 97
NL - Olanda 96
RU - Federazione Russa 69
IE - Irlanda 54
JO - Giordania 39
ZA - Sudafrica 37
FI - Finlandia 36
BG - Bulgaria 28
KR - Corea 27
NG - Nigeria 25
JP - Giappone 23
PK - Pakistan 23
TH - Thailandia 23
UA - Ucraina 23
CA - Canada 22
BD - Bangladesh 21
AR - Argentina 20
PH - Filippine 19
PL - Polonia 19
AT - Austria 17
CI - Costa d'Avorio 17
MX - Messico 15
EE - Estonia 13
ID - Indonesia 12
IQ - Iraq 11
EC - Ecuador 10
TG - Togo 10
TW - Taiwan 10
ES - Italia 8
BE - Belgio 7
PY - Paraguay 7
UZ - Uzbekistan 6
CL - Cile 5
CO - Colombia 5
LT - Lituania 5
GR - Grecia 4
HU - Ungheria 4
SA - Arabia Saudita 4
SC - Seychelles 4
TR - Turchia 4
AU - Australia 3
CH - Svizzera 3
ET - Etiopia 3
IL - Israele 3
IR - Iran 3
KE - Kenya 3
MY - Malesia 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
MT - Malta 2
PE - Perù 2
QA - Qatar 2
RS - Serbia 2
TN - Tunisia 2
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
LY - Libia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
ST - Sao Tome e Principe 1
SV - El Salvador 1
TZ - Tanzania 1
UY - Uruguay 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.146
Salva come PNG Salva come JPEG
Città #
Singapore 498
Ashburn 300
Ho Chi Minh City 259
San Jose 233
Hanoi 232
Southend 227
Hong Kong 226
Fairfield 213
Santa Clara 171
Woodbridge 123
Chandler 112
Houston 105
Seattle 94
Ann Arbor 91
Princeton 80
Wilmington 80
Cambridge 78
Beijing 69
Boardman 66
Los Angeles 56
Dublin 54
Hefei 47
Lauterbourg 40
Amman 39
Turin 39
Bologna 37
Da Nang 28
Haiphong 28
New York 28
Sofia 28
Council Bluffs 27
Abeokuta 25
Buffalo 25
Redmond 25
Redondo Beach 24
São Paulo 24
Helsinki 23
Westminster 23
Dong Ket 22
Chengdu 21
San Diego 21
Berlin 20
Tokyo 20
Milan 19
Munich 19
Biên Hòa 18
Abidjan 17
Shanghai 17
Nanjing 16
Des Moines 15
Frankfurt am Main 15
Guangzhou 15
Monzuno 14
Seoul 14
Warsaw 13
Bangkok 12
Hải Dương 12
Johannesburg 12
Vũng Tàu 12
Chicago 11
Dallas 11
Ninh Bình 11
Nuremberg 11
Changsha 10
Lomé 10
Quận Một 10
Saint Petersburg 10
Shenyang 10
Ha Long 9
Hebei 9
Jakarta 9
Nanchang 9
Padova 9
Phoenix 9
Atlanta 8
Brasília 8
Covent Garden 8
Falkenstein 8
Mexico City 8
Shenzhen 8
Thái Nguyên 8
Tianjin 8
Brooklyn 7
Brussels 7
Can Tho 7
Dearborn 7
Jacksonville 7
Jiaxing 7
Jinan 7
Lappeenranta 7
Muzaffargarh 7
Quận Bình Thạnh 7
Redwood City 7
San Francisco 7
Vienna 7
Wuhan 7
Belo Horizonte 6
Gujranwala 6
Hangzhou 6
Hyderabad 6
Totale 4.555
Salva come PNG Salva come JPEG
Nome #
Central and Peripheral Nervous Disorders 220
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data 219
Migraine chronification as an allostatic disorder: a proof-of-concept study 216
Greater Occipital Nerve Infiltration During Pregnancy in Cluster Headache: A Case Report 204
Idiopathic intracranial hypertension without papilledema (IIHWOP) in chronic refractory headache 202
A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years 192
Treatment of withdrawal headache in patients with medication overuse headache: a pilot study 190
Vessel-wall MRI in primary headaches: The role of neurogenic inflammation 176
Is physiotherapy in migraines known to sufferers? A cross-sectional study 175
Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study 170
Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache. 170
Interobserver reliability of ICSD-3 diagnostic criteria for disorders of arousal in adults 169
Clinical and radiological prognostic factors in spontaneous intracranial hypotension: a case series 168
Erenumab efficacy in highly resistant chronic migraine: a real-life study 167
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache 166
Migraine and sleep disorders. 161
Rotigotine Objectively Improves Sleep in Parkinson's Disease: An Open-Label Pilot Study with Actigraphic Recording 152
Transverse Sinus Stenosis in Refractory Chronic Headache Patients: An Observational Study 151
CGRP and migraine from a cardiovascular point of view: What do we expect from blocking CGRP? 148
The incidental finding of elevated anti GQ1B antibodies in a patient with selective small fiber neuropathy 147
State and trait anger and its expression in cluster headache compared with migraine: a cross-sectional study 146
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache 145
Quality indicators in headache care: an implementation study in six Italian specialist-care centres 141
Recurrent Reversible Cognitive Impairment in a Cluster Headache Patient: A Case Report 139
SPARTACUS: underdiagnosis of chronic daily headache in primary care. 138
SUNCT/SUNA and neurovascular compression: New cases and critical literature review. 136
Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center 136
Superficial siderosis associated with peripheral autonomic failure and tetraventricular hydrocephalus: a case report 134
Rare primary headaches in Italian tertiary Headache Centres: Three year nationwide retrospective data from the RegistRare Network 132
Migraine and cardiovascular diseases. 130
Energy Metabolism Impairment in Migraine 128
Idiopathic intracranial hypertension without papilledema in refractory chronic daily headache 128
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 127
Nociception and autonomic nervous system. 120
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study 118
Nummular headache: a gender-oriented perspective on a case series from the RegistRare Network 110
Vessel-wall MRI in thunderclap headache: A useful tool to answer the riddle? 102
Greater occipital nerve blockade in cluster headache: effectiveness and safety of a combined injection protocol 99
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs 98
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 97
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study) 96
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 93
P063. Colloid cysts of the third ventricle: a case report 91
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance 90
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 90
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 87
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 85
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study 84
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 83
The ultimate guide to the anti-CGRP monoclonal antibodies galaxy 80
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study 67
An unusual case of anti-basal ganglia encephalitis showing polyradiculoneuritis features 65
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 61
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 58
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men 46
Moving closer to the ideal migraine acute treatment 25
Totale 7.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 0 0 0 0 0 0 85
2021/2022635 37 16 41 31 63 20 13 85 21 75 142 91
2022/2023681 64 69 23 81 67 43 38 38 144 29 65 20
2023/2024290 10 42 23 47 11 51 24 19 8 29 9 17
2024/20251.286 50 239 90 71 220 65 60 43 11 100 59 278
2025/20263.075 528 206 212 209 289 141 346 208 572 205 97 62
Totale 7.268